Impact of PSCA Variation on Gastric Ulcer Susceptibility

• Chizu Tanikawa,

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Keitaro Matsuo,

  Affiliation Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan

  ⨯
• Michiaki Kubo,

  Affiliation Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Atsushi Takahashi,

  Affiliation Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Hidemi Ito,

  Affiliation Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan

  ⨯
• Hideo Tanaka,

  Affiliation Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan

  ⨯
• Yasushi Yatabe,

  Affiliation Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Research Institute, Aichi, Japan

  ⨯
• Kenji Yamao,

  Affiliation Department of Gastroenterology, Aichi Cancer Center Research Institute, Aichi, Japan

  ⨯
• Naoyuki Kamatani,

  Affiliation Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan

  ⨯
• Kazuo Tajima,

  Affiliation Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan

  ⨯
• Yusuke Nakamura,

  Affiliations Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, Departments of Medicine and Surgery, and Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Koichi Matsuda

  * E-mail: koichima@ims.u-tokyo.ac.jp

  Affiliation Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯